Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

By continuing you agree to the terms and privacy policy.

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories (in the app)
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • The whole archive
  • Your reading diet
  • Duki without the monthly limit

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Download on theApp StoreGet it onGoogle Play

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Live Terminal
Economy · Full coverage

Israeli Drug Firm Repa Secures Major US Defense Deal, Stock Soars

How 2 Israeli newsrooms covered this story — translated into English and compared side by side.

Unrated 2

By מערכת ice

First reported by Bizportal · 9 hours ago

What happened

Israeli pharmaceutical company Repa signed a five-year deal with the U.S. Defense Logistics Agency to supply emergency medical injectors, worth up to $257 million. The announcement caused Repa's stock to jump 35% in an hour.

  • 01Repa to supply emergency medical injectors to U.S. defense agency.
  • 02Deal valued up to $257 million over five years.
  • 03Repa's stock surged 35% following the announcement.
  • 04Agreement continues Repa's collaboration with U.S. security.
  • 05Highlights Israel's strength in medical technology sector.

Summary translated & synthesized from the sources below by baba. Read each original for the full report.

In this story
OrganizationsRepa, U.S. Defense Logistics Agency, U.S. Department of Defense, Olympus, BioProtect, Artivion, Endospan
PlacesIsrael, United States

Full coverage · 2 outlets

The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.

IceUnrated · Hebrew2 hours ago
Israeli Drug Firm Repa Secures Major US Defense Deal, Stock Soars
BizportalUnrated · Hebrew9 hours ago
Israeli Firm Rafa Secures Up to $257 Million US Defense Contract

Related stories

Teva to Supply Emergency Auto-Injectors to US Defense Department8 hours agoIsraeli Drugmaker Rafa Labs Receives Buy Recommendation Amid Growth ProspectsSep 9, 2026Aray Industries Stock Surges on Two New Defense DealsSep 14, 2026Israeli Companies Announce Medical Breakthroughs and InvestmentsSep 8, 2026Israeli Defense Firms Accelerate Production and Eye Public Listings Amid Prolonged ConflictsAug 2, 2026Israeli Startup Remepy Raises $36 Million to Develop AI-Driven Hybrid DrugsAug 12, 2026